Pimafucort 10mg/g+3500U/g+10mg/g cream for external use

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

natamycin, neomycin (neomycin sulfate), hydrocortisone (hydrocortisone micronized)

Available from:

Temmler Italia S.r.L.

ATC code:

D07CA01

INN (International Name):

natamycin, neomycin (neomycin sulfate), hydrocortisone (hydrocortisone micronized)

Dosage:

10mg/g+3500U/g+10mg/g

Pharmaceutical form:

cream for external use

Units in package:

aluminium or plastic tube 15g

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-05-06

Summary of Product characteristics

PIMAFUCORT, cream for external use
PIMAFUCORT, ointment for external use
Summary of Product Characteristics
1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
TRADE NAME OF THE MEDICINAL PRODUCT: Pimafucort
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_CREAM: _
1 g of cream contains:
_Active ingredients:_
natamycin 10 mg
neomycin (as neomycin sulfate) 3500 Units
hydrocortisone micronised 10 mg
_Excipients:_
Sodium citrate 14.0 mg, emulsifier F 115.0 mg, sorbitan stearate 30.0
mg, cetyl esters
wax
60.0
mg,
cetiol
V
150.0,
macrogol
stearate
100
20.0
mg,
methyl
parahydroxybenzoate 2.0 mg, propyl parahydroxybenzoate 0.50 mg,
purified water up to
1000.0 mg.
_OINTMENT: _
1 g of ointment contains:
_Active ingredients:_
natamycin 10 mg
neomycin (as neomycin sulfate) 3500 Units
hydrocortisone micronised 10 mg
_Excipients:_
Polyethylene ointment base (95 % of liquid paraffin, 5 % of
polyethylene) 976.5 mg.
3.
PHARMACEUTICAL FORM:
Cream for external use.
Ointment for external use.
DESCRIPTION
Cream: White to white with yellowish shade cream.
Ointment: White to yellow ointment.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Dermatoses
susceptible
to
glucocorticosteroid
therapy,
complicated
by
secondary
bacterial and/or fungal infection (especially, caused by fungi
Candida).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The medicine should be applied to the affected areas of skin in adults
and children 2-4
times per day. Duration of treatment is determined individually,
taking into account a
nature of disease, course of treatment usually does not exceed 14
days.
The medicine is recommended in the form of cream for the therapy of
acute and sub-
PIMAFUCORT, cream for external use
PIMAFUCORT, ointment for external use
Summary of Product Characteristics
2
acute dermatoses, including such states accompanied by weeping. The
ointment is
intended for the therapy of sub-acute and chronic dermatoses,
especially at the presence
of expressed dry skin, lichenification, seborrhea or in such cases
when the occlusive
properties of ointment are necessar